Background: Older patients (pts) with aortic valve stenosis suitable for transcatheter aortic valve implantation (TAVI) have an increased operative risk due to advanced age and co-morbidities. However current risk scores have been shown not to be the ideal tool to predict postinterventional outcome in this population. Frailty especially seems to be one of the major factors not included into these scores. Therefore aim of this study was to elucidate whether frailty assessment helps to predict outcome after TAVI. Methods: Pts were assessed prospectively regarding there over all appearance by two independent physicians and a numerical score from 1 (frail)-10 (good condition) was given. Additionally Katz activity score, gait speed testing, a five feet walk test and a hand grip strength test were performed. After 30days follow-up hemodynamic, clinical data as well as VARC safety endpoints were analysed. Results: A total of 75pts (age 81Ϯ6years) with a logEuroSCORE of 20.6Ϯ12.7% were treated. Almost ¾ of the pts received a Medtronic CoreValve and 19 an Edwards SAPIEN XT, two of them as valve-in-valve. The prostheses were successfully implanted in all pts. The mean gradient declined from 67.0Ϯ12.3 to 12.0Ϯ7.5mmHg. VARC success was achieved in 97.3%. The combined safety endpoint occurred in 24%. One pt died due to intracranial haemorrhage and one major stroke was noted. Thus major stroke and death occurred in 2.67%. Mean appearance score was 6.3Ϯ1.7, mean Katz activity score 5.4Ϯ1.4. Mean time to overcome five-feet was measured 8.5Ϯ4.2s. Mean hand grip strength of the dominant hand was 20.2Ϯ8.5Kg. There was no significant predictive value of hand grip strength and Katz score using a regression analysis (pϭ0.938; 0.925-1.089; pϭ0.301; 0.526-1.222). The reduced walking speed failed to reach the level of significance in this relatively small cohort (pϭ0.06; 0.991-1.529). Only the overall appearance score had significant predictive value for the occurrence of the combined safety endpoint (pϭ0.015; 0.280-0.873). Conclusions: TAVI in older pts with higher risk is safe, feasible and reliable. Frailty assessment provides additional information but individual clinical judgment remains crucial to insure beneficial outcome.
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Leveraging Preparatory Balloon Aortic Valvuloplasty (BAV)
Background: Valve-size selection for TAVI is based on annular measurements by echocardiography or CT. Still, relevant PAR with negative impact on survival is common(20%). We sought to evaluate whether supraaortic angiography during BAV may provide improved sizing(figure). Methods: Data of 167 consecutive pts with conventional sizing (echo,CT) (group 1) were compared to 103 successive pts, in which BAV was, additionally leveraged for size-selection (group 2). PAR was graded angiographically (Sellers criteria) and quantitatively using the pressure difference between diastolic aortic pressure and LVEDP (⌬P DAP-LVEDP) and the myocardial supply-demand ratio (DPTI:SPTI), a ⌬P DAP-LVEDPՅ18 mmHg and a DPTI:SPTIՅ0.7 having previously been proposed as cut-off values associated with increased cardiovascular mortality. Results: TAVI was successful in all pts (ES:166,MCV:103), PAR was observed in 113pts of gp1 and 41pts of gp2 (67vs40%, pϽ0.05). At least Moderate PAR, a ⌬p DAP-LVEDPՅ18 mmHg and a DPTI:SPTIՅ0.7 were observed more frequently in gp1 than gp2: 14.4vs7.8%, 26.3vs14.5% and 11.9vs6.7% (pϽ0.05). According to preinterventional imaging, 40pts had a borderline annulus size, raising uncertainty regarding valve-size selection. Balloon-sizing resulted in selection of the "bigger" prosthesis in 21pts; only 2 of these pts had relevant PAR. Cardiovascular mortality at 30 days&1-year was significantly decreased in gp2 compared to gp1 (5.8vs9% & 10.6vs20%, pϽ0.05).(no BAV-complications). Conclusions: Preparatory BAV during TAVI can be leveraged to improve valve-size selection and reduce associated PAR, especially in borderline cases.
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